The company issued an advisory July 30 regarding the medium-severity vulnerability, which affects Versions 2.24x and prior. The DreamMapper software is a personalized therapy adherence tool for sleep apnea patients but the vulnerability does not impact patient safety.
The issue would require a low skill level to exploit, which would allow unauthorized access to log file information containing descriptive error messages. The company has not received any reports that the vulnerability has been exploited to date.
Philips is planning a new DreamMapper release for June 30, 2021, to remediate the vulnerability.
More articles on cybersecurity:
January Beaumont email hack affected 6,000 patients: 4 details
NY hospital reverts to pen & paper after online breach: 4 details
Lifespan pays over $1M to settle HIPAA charge
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
